Inventiva (IVA) Cash & Equivalents (2018 - 2026)
Inventiva (IVA) reported Cash & Equivalents of $193.1 million for Q2 2026, up 39.7% from $138.19 million a year earlier.
Powered by 
Analysis
Inventiva (IVA) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Inventiva posted Cash & Equivalents of $115.6 million, up 12.0% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -0.9% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $103.19 million in FY2024 (+256.3%), $28.96 million in FY2023 (-67.3%), $88.49 million in FY2022 (-13.6%) and $102.43 million in FY2021 (-15.1%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents in data going back to Q4 2018.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2024 (growth of 256.3%); the low point was Q2 2024 (a decline of 67.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Inventiva | 716.91 Mn | -113.54 Mn | - | 189.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189.75 Mn |
| Dec 31, 2025 | 116.66 Mn |
| Jun 30, 2025 | 143.16 Mn |
| Dec 31, 2024 | 100.49 Mn |
| Jun 30, 2024 | 10.87 Mn |
| Dec 31, 2023 | 29.79 Mn |
| Jun 30, 2023 | 33.95 Mn |
| Dec 31, 2022 | 92.47 Mn |
| Jun 30, 2022 | 79.82 Mn |
| Dec 31, 2021 | 98.02 Mn |
| Jun 30, 2021 | 111.44 Mn |
| Mar 31, 2021 | 126.39 Mn |
| Dec 31, 2020 | 129.99 Mn |
| Jun 30, 2020 | 58.79 Mn |
| Dec 31, 2019 | 40.15 Mn |
| Dec 31, 2018 | 64.86 Mn |
API Access
Inventiva Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();